Today: 13 May 2026
Oklo Stock Rises After Earnings Show Wider 2025 Loss, Cash Hoard and Reactor Approvals
18 March 2026
2 mins read

Oklo Stock Rises After Earnings Show Wider 2025 Loss, Cash Hoard and Reactor Approvals

SANTA CLARA, California, March 17, 2026, 15:35 PDT.

  • Oklo reported a net loss of $105.7 million for 2025, a jump from $73.6 million the prior year. Shares lately traded at $60.53, up 1.4% on the day.
  • Liquidity at year-end was roughly $1.41 billion. Management expects investing cash outflows for 2026 to range between $350 million and $450 million.
  • Oklo picked up key approvals from the DOE and NRC on Tuesday, clearing hurdles for its Idaho reactor project and isotope initiatives in both Idaho and Texas.

Oklo on Tuesday posted a larger loss for 2025, underscoring the hefty outlays required to get a pioneer nuclear venture off the ground before major revenue kicks in. Still, with new U.S. approvals advancing its reactor and isotope initiatives, investors shrugged off the red ink and shares ended up a bit.

This update lands as advanced nuclear startups hustle to convert AI-driven power needs at data centers into firm deals. U.S. electricity demand is on track for all-time peaks in 2026 and 2027, according to forecasts. Back in January, Meta spotlighted nuclear, naming projects with Oklo, TerraPower, and Vistra.

Oklo’s annual report showed its net loss deepened to $105.7 million, up from $73.6 million in 2024. Operating losses also increased, hitting $139.3 million. Loss per Class A share, both basic and diluted, landed at 72 cents.

The company hasn’t booked any revenue from power or radioisotope sales so far. No reactor has been built yet, and there’s still no binding power purchase agreement in place for electricity or heat. The commercial pitch, for now, relies on permits that haven’t arrived, plus future fuel and customer contracts.

Oklo is sitting on a sizable pile of cash. By the end of 2025, cash and cash equivalents totaled $788.4 million, with another $624.1 million parked in marketable debt securities. Financing activities added roughly $1.26 billion for the year. Looking to 2026, management expects to burn through $80 million to $100 million on operations and set aside between $350 million and $450 million for investments.

Oklo said it received DOE approval for the safety-design deal on Aurora-INL, marking a milestone for its first reactor at Idaho National Laboratory. The company reached that point after signing an Other Transaction Agreement—an OTA—under the federal Reactor Pilot Program, which is meant to speed up advanced reactor projects. CEO Jacob DeWitte said this route “supports a stepwise approach” for rolling out the first unit. Business Wire

Atomic Alchemy, a subsidiary, picked up its first NRC materials license—clearing the way to handle and ship isotope material from its Idaho facility and kick off initial commercial sales. Separately, the Department of Energy signed off on the next phase of safety review for the Groves Isotopes Test Reactor in Texas. Oklo is aiming for reactor criticality by July 4, 2026. “Demand for critical isotopes is rising,” DeWitte noted. Business Wire

Oklo hasn’t shifted its target for deploying the first powerhouse—still 2028. The company highlighted a roster of prospective customers, referencing non-binding LOIs with Equinix, Diamondback, and Prometheus Hyperscale. It also underscored a 12-gigawatt master power agreement struck with Switch, plus that January prepayment from Meta tied to a 1.2-gigawatt site planned for Ohio; Meta’s broader deal also looped in TerraPower and Vistra.

The risks stick out. Oklo still has to secure more regulatory clearances, and its plans hinge on access to HALEU—high-assay low-enriched uranium—an upgraded fuel that’s essential for many next-gen reactors. According to the company, U.S. supplies are both scarce and expensive. Any snags in fuel delivery, licensing, or construction could easily knock the 2028 timeline off course and ramp up costs.

Nate Pendleton of Texas Capital Securities kept his Buy rating and $138 target in place Tuesday, describing the day’s disclosures as “important milestones” that help “de-risk” Oklo’s isotope business. Still, Oklo’s own filing spells it out: shares remain a bet on future execution rather than any current revenue stream. StreetInsider.com

Stock Market Today

  • Global Medical Response Goes Public with $479 Million IPO on NYSE
    May 13, 2026, 9:25 AM EDT. Global Medical Response (NYSE: GMRS) debuted on the New York Stock Exchange after completing a $479 million initial public offering (IPO). CEO Nick Loporcaro discussed the company's next steps during the NYSE Live segment. The IPO marks a significant milestone for GMRS as it enters public markets. Equities showed strength early in the session, boosted by the U.S. April Producer Price Index (PPI) report. Meanwhile, Sea Limited shares surged over 13% following a 38% revenue growth report. Rollins (NYSE: ROL) prepares to showcase its growth strategy at its 2026 Investor and Analyst Conference. Investors are watching IPO activity closely amid broader market resilience.

Latest articles

Crypto ATM Crackdown Spreads as $389 Million Scam Losses Put Kiosks in Crosshairs

Crypto ATM Crackdown Spreads as $389 Million Scam Losses Put Kiosks in Crosshairs

13 May 2026
Spokane Valley has ordered all virtual-currency kiosks removed within 30 days after police linked them to fraud and one suicide. The FBI reported $389 million in losses tied to crypto ATMs in 2025, with older adults suffering most. Minnesota banned the machines statewide this month. Industry groups argue such bans hurt legitimate users and dispute fraud allegations.
Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

13 May 2026
U.S. producer prices rose 1.4% in April, the largest monthly gain since March 2022, with the Producer Price Index up 6.0% year-over-year, the Bureau of Labor Statistics said Wednesday. Energy prices surged 7.8%, gasoline 15.6%. S&P 500 futures turned negative after the data. The American Petroleum Institute reported U.S. crude inventories fell by 2.2 million barrels last week.

Popular

Red Cat Stock Sinks as Discounted $225 Million Sale Tests Drone Boom Thesis

Red Cat Stock Sinks as Discounted $225 Million Sale Tests Drone Boom Thesis

13 May 2026
Red Cat priced 23.94 million new shares at $9.40, raising about $225 million and sending RCAT down 12% in premarket trading. The new shares represent nearly 20% dilution for existing holders. Q1 revenue surged 849% to $15.5 million, but the company posted a $26.6 million net loss and used $31.9 million in operating cash. Proceeds are for general corporate purposes, not a specific project.
Lululemon Stock Falls After Weak 2026 Outlook Overshadows Q4 Earnings Beat, Chip Bergh Joins Board
Previous Story

Lululemon Stock Falls After Weak 2026 Outlook Overshadows Q4 Earnings Beat, Chip Bergh Joins Board

Ondas Stock Price Holds Gains as ONDS Links New Deal to $140 Million Military Tender
Next Story

Ondas Stock Price Holds Gains as ONDS Links New Deal to $140 Million Military Tender

Go toTop